MiNK Therapeutics, Inc. SEC filings INKT
MiNK Therapeutics, Inc. has 265 filings in SEC EDGAR's recent list, going back to Jan 22, 2021. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 13, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Aug 13, 2026 | — |
| S-3/A | Filing | Dec 10, 2025 | — |
| S-3 | Shelf registration | Nov 7, 2025 | — |
| 424B5 | Prospectus supplement | Aug 22, 2025 | — |
| S-8 | Employee stock plan registration | Aug 14, 2025 | — |
| 424B5 | Prospectus supplement | Jul 15, 2025 | — |
| 424B3 | Prospectus | Aug 16, 2024 | — |
| S-3 | Shelf registration | Aug 13, 2024 | — |
| S-8 | Employee stock plan registration | Aug 13, 2024 | — |
| S-8 | Employee stock plan registration | Aug 11, 2023 | — |
| S-3 | Shelf registration | Nov 3, 2022 | — |
| S-8 | Employee stock plan registration | Jul 15, 2022 | — |
| 424B4 | Prospectus | Oct 15, 2021 | — |
| FWP | Free writing prospectus | Oct 15, 2021 | — |
| S-1/A | Amended registration statement | Oct 12, 2021 | — |
| S-1 | Registration statement | Sep 14, 2021 | — |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- INKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1840229
- Former names
- AgenTus Therapeutics, Inc. (until Mar 18, 2021); AgenTus Therapeutics, Inc. (until Mar 18, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.